Project Details
Description
A Study of ALT-803 in Patients with Relapsed or Refractory Multiple Myeloma
| Status | Finished |
|---|---|
| Effective start/end date | 2/7/15 → 5/30/21 |
Funding
- ALTOR BIOSCIENCE LLC
- NIH NATIONAL CANCER INSTITUTE (NCI)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.